IT8653307V0 - Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinale da detto dispositivo - Google Patents

Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinale da detto dispositivo

Info

Publication number
IT8653307V0
IT8653307V0 IT8653307U IT5330786U IT8653307V0 IT 8653307 V0 IT8653307 V0 IT 8653307V0 IT 8653307 U IT8653307 U IT 8653307U IT 5330786 U IT5330786 U IT 5330786U IT 8653307 V0 IT8653307 V0 IT 8653307V0
Authority
IT
Italy
Prior art keywords
adjust
including means
medicinal agent
initial duration
device including
Prior art date
Application number
IT8653307U
Other languages
English (en)
Italian (it)
Inventor
Atul Devdatt Ayer
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of IT8653307V0 publication Critical patent/IT8653307V0/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
IT8653307U 1985-04-22 1986-04-21 Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinale da detto dispositivo IT8653307V0 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/725,961 US4609374A (en) 1985-04-22 1985-04-22 Osmotic device comprising means for governing initial time of agent release therefrom

Publications (1)

Publication Number Publication Date
IT8653307V0 true IT8653307V0 (it) 1986-04-21

Family

ID=24916636

Family Applications (2)

Application Number Title Priority Date Filing Date
IT8653307U IT8653307V0 (it) 1985-04-22 1986-04-21 Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinale da detto dispositivo
IT67329/86A IT1188095B (it) 1985-04-22 1986-04-21 Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinali da detto dispositivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
IT67329/86A IT1188095B (it) 1985-04-22 1986-04-21 Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinali da detto dispositivo

Country Status (7)

Country Link
US (1) US4609374A (enExample)
JP (1) JPS61249917A (enExample)
CA (1) CA1246954A (enExample)
DE (1) DE3613433A1 (enExample)
FR (1) FR2580500B1 (enExample)
GB (1) GB2174300A (enExample)
IT (2) IT8653307V0 (enExample)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4662880A (en) * 1986-03-14 1987-05-05 Alza Corporation Pseudoephedrine, brompheniramine therapy
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
US4986987A (en) * 1986-05-09 1991-01-22 Alza Corporation Pulsed drug delivery
US5200196A (en) * 1986-05-09 1993-04-06 Alza Corporation Improvement in pulsed drug therapy
EP0265061B1 (en) * 1986-09-18 1992-01-08 London School of Pharmacy Innovations Ltd Pharmaceutical formulation
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
US4876093A (en) * 1987-07-02 1989-10-24 Alza Corporation Dispenser with dispersing member for delivering beneficial agent
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
DE4217104A1 (de) * 1992-05-22 1993-11-25 Salama Magdy Reservoir, Reservoir-System zur Inaktivierung, Hemmung und Eliminierung von Infektionserregern
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US6039975A (en) * 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
DE69735002T2 (de) * 1996-10-25 2006-10-26 Shire Laboratories, Inc. Osmotisches Verabreichungssystem für lösliche Dosen
US6361796B1 (en) 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
WO2001047498A2 (en) 1999-12-23 2001-07-05 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
DE60239868D1 (de) 2001-06-12 2011-06-09 Univ Johns Hopkins Med Reservoirvorrichtung für die intraokulare arzneimittelabgabe
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
AU2003269744A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited Oral osmotic controlled drug delivery system
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
MXPA04012976A (es) * 2002-06-17 2005-05-16 Alza Corp Sistema de distribucion osmotica con medio de potencia de empuje de orden cero temprana que comprende un agente osmotico disperso en el vehiculo fluido.
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
EP1691789B1 (en) * 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
CN104000779A (zh) 2007-04-23 2014-08-27 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
AU2010208046B2 (en) 2009-01-29 2014-10-02 Forsight Vision4, Inc. Posterior segment drug delivery
NO2462246T3 (enExample) 2009-09-28 2018-02-03
WO2013022801A1 (en) 2011-08-05 2013-02-14 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
JP6111194B2 (ja) 2010-08-05 2017-04-05 フォーサイト・ビジョン フォー・インコーポレーテッド 組み合わせ薬物送達方法および装置
EP2600930B1 (en) 2010-08-05 2021-02-17 ForSight Vision4, Inc. Injector apparatus for drug delivery
DK2600812T3 (da) 2010-08-05 2021-10-18 Forsight Vision4 Inc Apparat til at behandle et øje
AU2011329656B2 (en) 2010-11-19 2017-01-05 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
AU2011342893A1 (en) 2010-12-13 2013-05-02 Purdue Pharma L.P. Controlled release dosage forms
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP4249059B1 (en) 2011-06-28 2025-07-30 ForSight Vision4, Inc. An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
HUE054578T2 (hu) 2011-09-16 2021-09-28 Forsight Vision4 Inc Fluidumcserélõ berendezés
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
WO2014152959A1 (en) 2013-03-14 2014-09-25 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
CA2907681C (en) 2013-03-28 2022-11-22 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
EP3679908B1 (en) 2014-07-15 2024-09-04 ForSight Vision4, Inc. Ocular implant delivery device
CN107106551A (zh) 2014-08-08 2017-08-29 弗赛特影像4股份有限公司 受体酪氨酸激酶抑制剂的稳定且可溶的制剂和其制备方法
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
BR112017009660A2 (pt) 2014-11-10 2017-12-19 Forsight Vision4 Inc dispositivos de administração de fármacos expansíveis e métodos de utilização
US9579289B2 (en) 2015-02-20 2017-02-28 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
US11432959B2 (en) 2015-11-20 2022-09-06 Forsight Vision4, Inc. Porous structures for extended release drug delivery devices
US11617680B2 (en) 2016-04-05 2023-04-04 Forsight Vision4, Inc. Implantable ocular drug delivery devices
TWI754643B (zh) 2016-05-16 2022-02-11 美商因塔希亞治療公司 升糖素受體選擇性多肽和彼之使用方法
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
WO2018129058A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
JP7314155B2 (ja) 2017-11-21 2023-07-25 フォーサイト・ビジョン４・インコーポレーテッド 膨張可能ポート送達システムのための流体交換装置及びその使用方法
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN110045072B (zh) * 2019-04-19 2023-12-05 禄根仪器(镇江)有限公司 一种药物吸收系统及其吸收取样方法
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device
WO2025034784A1 (en) 2023-08-08 2025-02-13 United Therapeutics Corporation A method of producing an oral osmotic pharmaceutical delivery system and a pharmaceutical batch produced using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4522625A (en) * 1982-09-29 1985-06-11 Alza Corporation Drug dispenser comprising wall formed of semipermeable member and enteric member

Also Published As

Publication number Publication date
IT8667329A0 (it) 1986-04-21
GB8609216D0 (en) 1986-05-21
DE3613433A1 (de) 1986-10-23
US4609374A (en) 1986-09-02
JPS61249917A (ja) 1986-11-07
IT1188095B (it) 1987-12-30
GB2174300B (enExample) 1989-07-05
GB2174300A (en) 1986-11-05
CA1246954A (en) 1988-12-20
FR2580500B1 (fr) 1988-09-16
FR2580500A1 (fr) 1986-10-24

Similar Documents

Publication Publication Date Title
IT1188095B (it) Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinali da detto dispositivo
IT1195817B (it) Dispositivo a cessione controllata per la somministrazione di un agente benefico a un recettore
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
IT1182253B (it) Dispositivo ad azione osmotica per la somministrazione di un agente benefico all ambiente circostante particolarmente per la somministrazione di farmaci in ambito gastrointe stinale
IT1169806B (it) Dispositivo per la somministrazione controllata di farmaci
ES549639A0 (es) Dispositivo osmotico para la administracion controlada de unagente benefico a un ambiente de utilizacion
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
IT8267175A0 (it) Unita di dosaggio per la sommini strazione contemporanea di un medicamento e di un intensificatore di assorbimento percutaneo
IT1195819B (it) Dispositivo erogatore per la somministrazione con portata di erogazione controllata di un agente terapeutico
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
IT1128094B (it) Catetere per la somministrazione en dovenosa intermittente di medicamenti
DK16487D0 (da) Vacciner til oral indgift
IT1188098B (it) Dispositivo per l erogazione di farmaci
DK464383D0 (da) Medikamentadministreringsapparat
IT1142370B (it) Dispositivo per la somministrazione di gas anestetico
IT1195818B (it) Dispositivo erogatore per somministrare un agente terapeutico all ambiente d uso provvisto di mezzi per incrementare l erogazione di detto agente
IT8147821A0 (it) Di sostanze medicamentose dispositivo per la somministrazione
IT8248677A0 (it) Formulazioni farmaceutiche
IT1198247B (it) Formulazioni farmaceutiche acquose di ubichinone
IT1156105B (it) Composizioni farmaceutiche per il trattamento della pelle
IT1213080B (it) Sistemi terapeutico per la cessione controllata di farmaci.
IT8748554A0 (it) Associazione medicamentosa
BE890817A (fr) Medicaments pschycotropes
RO83061A3 (ro) Praf de dinti medicinal
RO91711A2 (ro) Produs medicamentos reconfortant